ArticleAmerican journal of translational research2023

Concurrent chemoradiotherapy improves prognosis and quality of life of patients with metastatic and recurrent hepatocellular carcinoma.

Shugang Sun et al.PubMed ↗Full text ↗

No numbers read from the abstract.